Doubting the Upside<br />By Rev Shark<br />RealMoney.com Contributor<br />2/10/2010 8:41 AM EST<br /><br /> A pessimist is one who feels bad when he feels good for fear he'll feel worse when he feels better.<br /> -- Unknown<br /><br />Talk of a Greek bailout by Germany helped the market to produce a decent bounce on Tuesday. We were quite oversold already, so the news made for a convenient excuse to do some buying, but I suspect we would have seen some upside even without the news about Greece.<br /><br />Even though the bounce was big and broad, however, it didn't have the feel that bottom-fishers were anxious to rush in. It just wasn't that upbeat despite the gains. Last year when we had a bounce like this, there was always the feeling that this was the last chance to jump in before the elevator ride back up to highs.<br /><br />The downtrend of the last few weeks has affected sentiment. When our first two bounce attempts failed, the dip-buying bulls finally had to admit that maybe the market doesn't always recover in "V"-shaped fashion. There is much more nervousness now and less confidence, which may ultimately be bullish but in the shorter term is dangerous.<br /><br />We are now on our third bounce attempt since the top in mid-January, and it'll be very interesting to see what the bulls can put together this time. I certainly wasn't very impressed yesterday, especially with the mediocre close and given that we were so sensitive to any news about Greece. Strong markets run regardless of news considerations.<br /><br />Market players are very focused on the dollar, and any further rally will likely be predicated on a weaker greenback. With the problems in Europe, the dollar has been trending up lately. It bounced back up yesterday on the Greek bailout news, which is what helped propel oil, commodities and the other groups that led the action yesterday.<br /><br />At this point I remain skeptical and distrustful of further bounces. We could bounce as high as 1100 on the S&P 500 and really not change the character of this market, but the bulls need to be much more upbeat and energetic if they are going to generate the momentum to get even that far.<br /><br />The main thing that prevents me from being more positive about this market is that there still is absolutely no decent leadership and there just aren't many good charts. I see a lot of dead-cat bounces and moves back to resistance, but we just haven't had enough time yet to build bases or to find good support. The long-side plays are all just quick oversold bounces that you have to quickly flip. There is very little that I see that justifies the building of longer-term positions.<br /><br />On the other hand, there are ton of potential short setups developing as stocks bounce back to resistance on lower volume. This is the pattern that killed the bears very often last year when a "V"-shaped move developed, but this time we just aren't bouncing like we have in the past.<br /><br />I'd love to buy some longs aggressively, but they just aren't there right now. That doesn't mean we won't bounce some more, but I have no confidence in sustained upside at this time.<br /><br />Last night we had a great report from Baidu (BIDU) and one from Disney (DIS) that trapped some overeager bulls. Overseas markets were mostly up but the dollar is stronger this morning and is keeping the early action flat. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: MCZ +47.1%, NTGR +14.7%, QUIK +9.9%, BIDU +8.7%, LIOX +8.0%, CPST +6.1% (also upgraded to Outperform from Market Perform at Northland Securities), FNSR +6.1%, SVM +5.2%, DIOD +5.0%, SGEN +4.9%, DSCM +4.7%, MICC +4.4%, RMTR +3.8%, AZPN +3.0%, CERN +1.8% ... Select European financials showing strength: ING +3.4%, PUK +3.4%, BCS +3.0%, CS +2.1%, RBS +2.0%, HBC +1.3%... Other news: ATHX +25.0% (receives U.S. patent covering adult stem cell composition & production), ALXA +21.7% (Biovail enters into license and collaboration agreement with Alexza for AZ-004), HYTM +12.5% (announces peer-reviewed publication of randomized, double-blind, placebo-controlled study ), ONCY +11.9% (continued strength from this week's 20% jump), LFC +3.9% (light volume, to speed up business structure adjustment in 2010 - Xinhua), TSRA +3.9% (will replace Financial Federal in the S&P SmallCap 600 index), CEO +3.3% (partner Husky finds gas field in S.China Sea - China Daily), MITI +2.7% (still checking), TM +2.0% (still checking for anything specific)... Analyst comments: ADBE +4.5% (upgraded to Outperform from Neutral at Credit Suisse), DELL +3.3% (upgraded to Buy at BofA/Merrill), VE +1.8% (upgraded to Neutral from Sell at UBS ), NYX +1.1% (upgraded to Outperform from Underperform at Calyon), FWLT +1.1% (upgraded to Buy from Neutral at Davenport).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: DF -7.9% MT -5.2%, EXBD -4.8%, LNCE -3.8%, PSEC -3.3%, ICE -3.2%, LGF -3.1%, ASEI -3.0%, BOBE -2.8%, S -2.7%, CXW -2.3%, EOG -2.2%, DIS -1.5%, BHP -1.3%... Select airline names ticking lower: DAL -2.7%, AMR -2.0%, LCC -1.9%... Other news: ISIS -13.9% (Genzyme announces Mipomersen phase 3 study results), MU -2.5% (announces agreement to acquire Numonyx in all-stock transaction), GSK -2.1% (trading ex dividend), SYT -1.7% (still checking), NOK -1.4% (still checking), RDS.A -1.2% (trading ex dividend)... Analyst comments: ENER -3.1% (downgraded to Sell from Neutral at UBS), PKY -2.0% (downgraded to Underperform at Raymond James), CRXL -1.7% (downgraded to Neutral from Buy at UBS), MEE -1.6% (downgraded to Neutral from Overweight at JP Morgan), TLVT -1.4% (downgraded to Neutral from Overweight at Piper Jaffray).